2023-05-04 16:42:31 ET
- Select Medical press release ( NYSE: SEM ): Q1 GAAP EPS of $0.37 misses by $0.05 .
- Revenue of $1.6B (flat Y/Y) misses by $50M .
- Select Medical continues to expect consolidated revenue to be in the range of $6.5 billion to $6.7 billion for the full year of 2023 vs $6.60B consensus. Select Medical is also issuing its 2023 business outlook for Adjusted EBITDA and fully diluted earnings per common share. Select Medical expects Adjusted EBITDA to be in the range of $780.0 million to $820.0 million and fully diluted earnings per common share to be in the range of $1.75 to $1.99. A reconciliation of full year 2023 Adjusted EBITDA expectations to net income is presented in table VII of this release.
For further details see:
Select Medical GAAP EPS of $0.37 misses by $0.05, revenue of $1.6B misses by $50M